Alphageneron Pharmaceuticals
New York, US · Founded 2020 · Delaware corporation
Find your way into Alphageneron Pharmaceuticals
Sign up to see every warm intro you have to Alphageneron Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alphageneron Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RB
Robert BrooksNamed on SEC filing
OS
Ola SoderquistNamed on SEC filing
ML
Marc LippmanNamed on SEC filing
BV
Bikash VermaNamed on SEC filing
RC
Robert ClarkeNamed on SEC filing
GP
Graham PockleyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2023
▶$250KraisedAug 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedAug 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrooksExecutive Officer, Director
- Ola SoderquistExecutive Officer
- Marc LippmanDirector
- Bikash VermaDirector
- Robert ClarkeDirector
- Graham PockleyExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alphageneron Pharmaceuticals raised?
- Alphageneron Pharmaceuticals has disclosed $250K raised across 1 round.
- Where is Alphageneron Pharmaceuticals headquartered?
- Alphageneron Pharmaceuticals is headquartered in New York, US.